patient
|
6 |
Age
|
39 |
Gender
|
male |
Origin
|
Germany |
Genotype
|
D |
PC_CP mutation
|
wt |
Weight(kg)
|
86 |
Duration of Pretreatment with Lamivudine (mo)
|
60 |
HBeAg Status at Baseline ADV
|
positive |
HBV DNA at Baseline ADV (log10 copies/mL)
|
9.18 |
Duration of ADV Therapy (mo)
|
13 |
HBV DNA at Baseline TDF (log10 copies/mL)
|
7.41 |